Clinical trial
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use…
NCT00487513 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00487513 |
|---|---|
| Title | Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials |
| Official title | Procurement of Follicular B Cell Lymphoma Cells From Blood, Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials: A Minimal Risk Protocol |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Procedure |
| Interventions | Procurement of Follicular B Cell Lymphoma Cells |
| Enrollment | 40 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Jun 18, 2007 |
| Last update posted | Mar 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: